Brian Naiman

1.9k total citations
16 papers, 1.0k citations indexed

About

Brian Naiman is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Brian Naiman has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Brian Naiman's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Leptospirosis research and findings (2 papers). Brian Naiman is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Leptospirosis research and findings (2 papers). Brian Naiman collaborates with scholars based in United States, Sweden and United Kingdom. Brian Naiman's co-authors include Cynthia L. Baldwin, Richard L. Zuerner, Carole A. Bolin, David P. Alt, Per‐Johan Jakobsson, Marsha L. Roach, Sipra Saha, Thomas J. Carty, Jeffrey L. Stock and Karamjeet Pandher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Brian Naiman

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Naiman United States 11 314 305 298 176 129 16 1.0k
Dae Yong Kim South Korea 22 66 0.2× 471 1.5× 212 0.7× 107 0.6× 133 1.0× 53 1.4k
David R. Webb United States 15 108 0.3× 220 0.7× 433 1.5× 75 0.4× 74 0.6× 38 822
Liana Verinaud Brazil 21 63 0.2× 311 1.0× 362 1.2× 45 0.3× 71 0.6× 61 1.1k
Yonghong Zhu China 23 126 0.4× 838 2.7× 132 0.4× 20 0.1× 204 1.6× 43 1.5k
Tamara Tanos Argentina 18 32 0.1× 796 2.6× 205 0.7× 153 0.9× 157 1.2× 23 1.5k
Michele M. Barsante Brazil 15 44 0.1× 225 0.7× 359 1.2× 195 1.1× 19 0.1× 18 904
G P Linette United States 10 39 0.1× 484 1.6× 158 0.5× 154 0.9× 37 0.3× 15 916
Jianping Pan China 20 61 0.2× 480 1.6× 448 1.5× 23 0.1× 65 0.5× 43 1.2k
Barbara Magi Italy 20 42 0.1× 638 2.1× 187 0.6× 49 0.3× 85 0.7× 37 1.5k
Pedro Ostoa‐Saloma Mexico 14 24 0.1× 328 1.1× 206 0.7× 219 1.2× 56 0.4× 45 971

Countries citing papers authored by Brian Naiman

Since Specialization
Citations

This map shows the geographic impact of Brian Naiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Naiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Naiman more than expected).

Fields of papers citing papers by Brian Naiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Naiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Naiman. The network helps show where Brian Naiman may publish in the future.

Co-authorship network of co-authors of Brian Naiman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Naiman. A scholar is included among the top collaborators of Brian Naiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Naiman. Brian Naiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Malhotra, Deepali, Eleanor Clancy‐Thompson, Bilal Omar, et al.. (2022). 469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT. Regular and Young Investigator Award Abstracts. A489–A489. 5 indexed citations
2.
Vousden, Katherine A., T. Lundqvist, Bojana Popovic, et al.. (2019). Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1. Scientific Reports. 9(1). 1605–1605. 24 indexed citations
3.
Karnell, Jodi L., Qiming Wang, Shu Wang, et al.. (2017). Autoimmune manifestations in aged mice arise from early-life immune dysregulation. The Journal of Immunology. 198(Supplement_1). 54.1–54.1. 1 indexed citations
4.
Wang, Shu, Jingya Wang, Varsha Kumar, et al.. (2017). Role and Regulation of CD11chi T-bet+ B cells in SLE. The Journal of Immunology. 198(Supplement_1). 54.4–54.4. 1 indexed citations
5.
Wang, Jingya, Jodi L. Karnell, Qiming Wang, et al.. (2016). Autoimmune manifestations in aged mice arise from early-life immune dysregulation. Science Translational Medicine. 8(361). 361ra137–361ra137. 39 indexed citations
6.
Le, Catherine T., Christopher Morehouse, Brian Naiman, et al.. (2015). Synergistic Actions of Blocking Angiopoietin-2 and Tumor Necrosis Factor-α in Suppressing Remodeling of Blood Vessels and Lymphatics in Airway Inflammation. American Journal Of Pathology. 185(11). 2949–2968. 23 indexed citations
7.
Chen, Bo, Allison L. Miller, Marlon C. Rebelatto, et al.. (2015). S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo. PLoS ONE. 10(2). e0115828–e0115828. 95 indexed citations
8.
An, Ling–Ling, Payal Mehta, Linda Xu, et al.. (2014). Complement C5a potentiates uric acid crystal‐induced IL‐1β production. European Journal of Immunology. 44(12). 3669–3679. 55 indexed citations
9.
Krausz, Sarah, Samuel García, Carmen A. Ambarus, et al.. (2012). Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis. Annals of the Rheumatic Diseases. 71(8). 1402–1410. 38 indexed citations
10.
Chen, Bo, Ricardo Cibotti, Brian Naiman, et al.. (2008). Genomic-Based High Throughput Screening Identifies Small Molecules That Differentially Inhibit the Antiviral and Immunomodulatory Effects of IFN-α. Molecular Medicine. 14(7-8). 374–382. 3 indexed citations
11.
Trebino, Catherine E., Jeffrey L. Stock, Colleen P. Gibbons, et al.. (2003). Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proceedings of the National Academy of Sciences. 100(15). 9044–9049. 471 indexed citations
12.
Baldwin, Cynthia L., Brian Naiman, Rachel A. Brown, et al.. (2002). Activation of bovine peripheral blood γδ T cells for cell division and IFN-γ production. Veterinary Immunology and Immunopathology. 87(3-4). 251–259. 42 indexed citations
13.
Naiman, Brian, et al.. (2002). Immunological characterization of a γδ T‐cell stimulatory ligand on autologous monocytes. Immunology. 105(2). 181–189. 17 indexed citations
14.
Naiman, Brian, Seth L. Blumerman, David P. Alt, et al.. (2002). Evaluation of Type 1 Immune Response in Naive and Vaccinated Animals following Challenge withLeptospira borgpeterseniiSerovar Hardjo: Involvement of WC1+γδ and CD4 T Cells. Infection and Immunity. 70(11). 6147–6157. 80 indexed citations
15.
Blumerman, Seth L., et al.. (2002). Expression of the bovine high affinity IL-12 receptor β2. Veterinary Immunology and Immunopathology. 84(3-4). 127–142. 8 indexed citations
16.
Naiman, Brian, David P. Alt, Carole A. Bolin, Richard L. Zuerner, & Cynthia L. Baldwin. (2001). Protective KilledLeptospira borgpeterseniiVaccine Induces Potent Th1 Immunity Comprising Responses by CD4 and γδ T Lymphocytes. Infection and Immunity. 69(12). 7550–7558. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026